Transforming growth factor-beta (TGF-β) and brain tumours

被引：32

作者：

Luwor, Rodney B. ^{[1
]}

Kaye, Andrew H. ^{[1
,2
]}

Zhu, Hong-Han ^{[1
]}

机构：

[1] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia

[2] Univ Melbourne, Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic 3050, Australia

来源：

JOURNAL OF CLINICAL NEUROSCIENCE | 2008年 / 15卷 / 08期

关键词：

glioma; signalling; TGF-beta; therapy;

D O I：

10.1016/j.jocn.2008.01.003

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Since its discovery in the late 1970s considerable research has linked transforming growth factor-beta (TGF-beta) to several human diseases such as fibrosis, auto-immunity and cancer. TGF-beta acts initially as a growth inhibitory factor in early stages of tumour development. In contrast, as tumours evolve, they develop mechanisms to evade the growth-regulatory effects of TGF-beta, resulting in greater tumour invasiveness, increased metastatic potential and inhibition of surrounding immune responses. However, although extensively studied, the molecular mechanisms that trigger tumour cells to "switch" from TGF-beta-inhibited to TGF-beta-promoted are still not fully understood. Contradictory studies that demonstrate opposite cellular effects mediated by TGF-beta are abundant throughout the literature. This review summarizes the current molecular mechanisms involved in the tumour suppressive and tumour progressive characteristics of TGF-beta in brain tumours. Potential therapeutic agents that target TGF-beta and related proteins being evaluated against brain tumours is also discussed. (c) 2008 Elsevier Ltd. All rights reserved.

引用

页码：845 / 855

页数：11

共 110 条

[31] Interaction of transforming growth factor-β (TGF-β) and epidermal growth factor (EGF) in human glioma cells [J].

Held-Feindt, J ;

Lütjohann, B ;

Ungefroren, H ;

Mehdorn, HM ;

Mentlein, R .

JOURNAL OF NEURO-ONCOLOGY, 2003, 63 (02) :117-127

[32] TGF-beta signalling from cell membrane to nucleus through SMAD proteins [J].

Heldin, CH ;

Miyazono, K ;

tenDijke, P .

NATURE, 1997, 390 (6659) :465-471

[33] TYPE BETA-TRANSFORMING GROWTH-FACTOR AND EPIDERMAL GROWTH-FACTOR SUPPRESS THE PLASMINOGEN-ACTIVATOR ACTIVITY IN A HUMAN GLIOBLASTOMA CELL-LINE [J].

HELSETH, E ;

DALEN, A ;

UNSGAARD, G ;

VIK, R .

JOURNAL OF NEURO-ONCOLOGY, 1988, 6 (03) :277-283

[34]

Hjelmeland MD, 2004, MOL CANCER THER, V3, P737

[35] DISTRIBUTION OF TRANSFORMING GROWTH FACTOR-BETA(1) IN HUMAN ASTROCYTOMAS [J].

HORST, HA ;

SCHEITHAUER, BW ;

KELLY, PJ ;

KOVACH, JS .

HUMAN PATHOLOGY, 1992, 23 (11) :1284-1288

[36] TRANSFORMING GROWTH FACTOR-BETA-S INHIBIT MITOGEN-STIMULATED PROLIFERATION OF ASTROCYTES [J].

HUNTER, KE ;

SPORN, MB ;

DAVIES, AM .

GLIA, 1993, 7 (03) :203-211

[37]

Iavarone A, 1997, NATURE, V387, P417

[38] Resistance to growth inhibition by transforming growth factor-β in malignant glioma cells with functional receptors [J].

Isoe, S ;

Naganuma, H ;

Nakano, S ;

Sasaki, A ;

Satoh, E ;

Nagasaka, M ;

Maeda, S ;

Nukui, H .

JOURNAL OF NEUROSURGERY, 1998, 88 (03) :529-534

[39] Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas [J].

Izumoto, S ;

Arita, N ;

Ohnishi, T ;

Hiraga, S ;

Taki, T ;

Tomita, N ;

Ohue, M ;

Hayakawa, T .

CANCER LETTERS, 1997, 112 (02) :251-256

[40]

Izumoto S, 1996, CANCER RES, V56, P1440

← 1 2 3 4 5 6 7 8 9 10 →